Wolverine Stack (BPC-157 + TB-500): What the Research Shows

A research overview of the Wolverine Stack (BPC-157 + TB-500): the two tissue-repair research peptides, what published studies examined, and lab handling. For research use only.

The Wolverine Stack combines two peptides — BPC-157 and TB-500 — that are frequently studied together in tissue-repair research. This guide summarizes what the published scientific literature has examined about each component, their molecular profiles, and how the blend is handled in a research setting. It is written for researchers and is not medical guidance.

What is the Wolverine Stack?

This is a two-component research blend:

  • BPC-157 (CAS 137525-51-0) — a synthetic pentadecapeptide derived from a body-protection-compound sequence. See our dedicated BPC-157 research guide.
  • TB-500 (CAS 77591-33-4) — a synthetic fragment related to thymosin beta-4, a naturally occurring actin-binding peptide studied in tissue-repair models.

Research-use note: This blend is supplied strictly for laboratory research. It is not an approved drug or supplement and is not for human or animal consumption. Findings below come from cell-culture and animal-model studies.

How the blend works (the mechanism studied)

The two peptides are studied along complementary research pathways. BPC-157 has been examined in tendon, muscle, and gastrointestinal models, while thymosin beta-4 (the basis of TB-500) is studied as an actin-binding peptide associated with cell migration and angiogenesis. Researchers combine them to study soft-tissue research endpoints in parallel.

What researchers have studied

  • BPC-157 — Chang et al. (J Appl Physiol, 2011) examined tendon fibroblast outgrowth and migration in cultured cells.
  • Thymosin beta-4 (TB-500) — Malinda et al. (FASEB J, 1999) reported that thymosin beta-4 accelerates wound healing in animal models; Goldstein et al. (2010) reviewed it as a multifunctional tissue-repair peptide.

These findings describe research outcomes in laboratory models, not validated outcomes in humans.

Handling and reconstitution in the laboratory

The blend is typically supplied as a lyophilized powder for research use. Standard laboratory practice is to reconstitute it with bacteriostatic water, swirl (not shake) until dissolved, and store the reconstituted solution refrigerated (2–8 °C). The lyophilized powder is generally stored frozen and protected from light. (General lab-handling notes, not usage instructions.)

For research use only

All products and information referenced here are intended strictly for laboratory and scientific research use only. They are not for human or animal consumption and are not drugs, foods, supplements, or medical devices. No statement here should be interpreted as medical advice.

Explore this blend and related research peptides

References

  1. Chang CH, et al. The promoting effect of pentadecapeptide BPC 157 on tendon healing. J Appl Physiol. 2011. PubMed
  2. Malinda KM, et al. Thymosin beta4 accelerates wound healing. J Invest Dermatol. 1999. PubMed
  3. Goldstein AL, et al. Thymosin beta4: a multifunctional tissue repair and regeneration peptide (animal studies). 2010. PubMed

Related comparison: BPC-157 vs TB-500 — how the research peptides compare.